May 3, 2017

Study bringing more precision medicine to Ontario’s cancer patients

The advent of genomic sequencing and targeted therapies has opened the door to new ways of diagnosing and treating cancer. The Ontario-wide Cancer Targeted Nucleic Acid Evaluation (OCTANE) program is a new, province-wide initiative supported by OICR that will allow more patients to benefit from these innovations while also helping to advance cancer research in Ontario.

Continue reading – Study bringing more precision medicine to Ontario’s cancer patients

Tags: Adaptive Oncology, cBioPortal, Clinical trials, Computational Biology and Genome Informatics, Genomics, Hamilton, John Bartlett, Juravinski, Kingston, Kingston General Hospital, Lillian Siu, London, London Health Sciences Centre, OCTANE, Ontario Tumour Bank, Ottawa, Philip Awadalla, Philippe Bedard, Standards development, The Ottawa Hospital, Translational Genomics Laboratory, University Health Network